Antibody cross-competition analysis of the human immunodeficiency virus type 1 gp120 exterior envelope glycoprotein

Journal of Virology

Volumn 70, Issue 3, 1996, Pages 1863-1872

  Moore, John P ^a   Sodroski, Joseph ^b,c,d  

^a AARON DIAMOND AIDS RESEARCH CENTER   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; VIRUS RECEPTOR;

ANIMAL CELL; ANTIGEN ANTIBODY REACTION; ANTIGEN BINDING; ARTICLE; COMPETITIVE INHIBITION; COMPLEX FORMATION; CROSS REACTION; GENE CLUSTER; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; VIRUS ENVELOPE; VIRUS NEUTRALIZATION;

EID: 0030043169     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.3.1863-1872.1996     Document Type: Article

References (62)

1. Allaway, G., A. M. Ryder, G. A. Beaudry, and P. J. Maddon. 1993. Synergistic inhibition of HIV-1 envelope-mediated cell fusion by CD4-based molecules in combination with antibodies to gp120 or gp41. AIDS Res. Hum Retroviruses 9:581-587
2. Bernstein, H. B., S. P. Tucker, E. Hunter, J. S. Schutzbach, and R. W. Compans. 1994. Human immunodeficiency virus type 1 envelope glycoprotein is modified by O-linked oligosaccharides. J. Virol. 68:463-468.
3. Buchacher, A., R. Predl, K. Strutzenberger, W. Steinfellner, A. Trkola, M. Purtscher, G. Gruber, C. Tauer, F. Steindl, A. Jungbauer, and H. Katinger. 1994. Electrofusion and EBV-transformation for PBL-immortalization; generation of human monoclonal antibodies against HIV-1 proteins. AIDS Res. Hum. Retroviruses 10:359-369.
4. Buchbinder, A., S. Karwowska, M. K. Corny, S. T. Burda, and S. Zolla-Pazner. 1992 Synergy between human monoclonal antibodies extends their effective biological activity against homologous and divergent strains. AIDS Res. Hum. Retroviruses 8:425-427.
5. Burton, D. R., J. Pyati, R. Koduri, G. B. Thornton, L. S. W. Sawyer, R. M. Hendry, N. Dunlop, P. L. Nara, M. Lamacchia, E. Garratty, E. R. Stiehm. Y. J. Bryson, J. P. Moore, D. D. Ho, and C. F. Barbas III. 1994 Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody. Science 266:1024-1027.
6. Capon, D. J., S. M. Chamow, J. Mordenti, S. A. Marsters, T. Gregory, H. Mitsuya, R. A. Byrn, C. Lucas, F. M. Wurm, J. E. Groopman, and D. H. Smith. 1989. Designing CD4 immunoadhesins for AIDS therapy. Nature (London) 337:525-531.
7. Choe, H.-R., and J. Sodroski. 1995. Adaptation of human immunodeficiency virus type 1 to cells expressing a binding-deficient CD4 mutant (lysine 46 to aspartic acid). J. Virol. 69:2801-2810.
8. Decroly, E., B. Cornet, I. Martin, J.-M. Ruysschaert, and M. Vandenbranden. 1993 Secondary structure of gp160 and gp120 envelope glycoproteins of human immunodeficiency virus type 1: a Fourier transform infrared spectroscopic study J. Virol. 67:3552-3560.
9. Freed, E. O., and M. A. Martin. 1994. Evidence for a functional interaction between the V1/V2 and C4 domains of human immunodeficiency virus type 1 envelope glycoprotein gp120. J. Virol. 68:2503-2512.
10. Fung, M. S. C., C. R. Y. Sun, W. L. Gordon, R-S. Liou, T. W. Chang, W. N. C. Sun, E. S. Daar, and D. D. Ho. 1992 Identification and characterization of a neutralization site within the second variable region of human immunodeficiency virus type 1 gp120. J. Virol. 66:848-856.
11. Gallaher, W. R., J. M. Ball, R. F. Carry, A. M. Martin-Amedec, and R. C. Montelaro. 1995. A general model for the surface glycoproteins of HIV and other retroviruses. AIDS Res. Hum. Retroviruses 11:191-202.
12. Hansen, J.-E. S., H. Clausen, S.-L. Hu, J. O. Nielsen, and S. Olofsson. 1992. An O-linked carbohydrate neutralization epitope of HIV-1 gp120 is expressed by HIV-1 env gene recombinant vaccinia virus. Arch. Virol. 126:11-20
13. Helseth, E., U. Olshevsky, C. Furman, and J. Sodroski. 1991. Human immunodeficiency virus type 1 gp120 envelope glycoprotein regions important for association with the gp41 transmembrane glycoprotein J. Virol. 65:2119-2123
14. Ho, D. D., M. S. C. Fung, Y. Cao, X. L. Li, C. Sun, T. W. Chang, and N.-C. Sun. 1991. Another discontinuous epitope on glycoprotein gp120 that is important in human immunodeficiency virus type 1 neutralization is identified by a monoclonal antibody. Proc. Natl Acad. Sci. USA 88:8949-8952.
15. Ho, D. D., J. A. McKeating, X. L. Li, T. Moudgil, E. S. Daar, N-C. Sun, and J. E. Robinson. 1991. Conformational epitope on gp120 important in CD4 binding and human immunodeficiency virus type 1 neutralization identified by a human monoclonal antibody. J. Virol. 65:489-493.
16. Rang, C.-Y., K. Hariharan, P. L. Nara, J. Sodroski, and J. P. Moore. 1994. Immunization with a soluble CD4-gp120 complex preferentially induces neutralizing anti-human immunodeficiency virus type 1 antibodies directed to conformation-dependent epitopes of gp120. J. Virol. 68:5854-5862
17. Kinney-Thomas, E., J. N. Weber, J. McClure, P. R. Clapham, M. C. Singhal, M. K. Shriver, and R. A. Weiss. 1988. Neutralising monoclonal antibodies to the AIDS virus. AIDS 2:25-29.
18. Koito, A., L., Stamatatos, and C. Cheng-Mayer. 1995 Small amino acid sequence changes within the V2 domain can affect the function of a T-cell line-tropic human immunodeficiency virus type 1 envelope gp120. Virology 206:878-884.
19. Kowalski, M. L., J. Potz, L. Basiripour, T. Dorfman, W. C. Goh, E. Terwilliger, A. Dayton, C. Rosen, W. Haseltine, and J. Sodroski. 1987. Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1. Science 237:1351-1355.
20. Langedijk, J. P. M., N. K. T. Back, E. Kinney-Thomas, C. Bruck, M. Francotte, J. Goudsmit, and R. H. Meloen. 1992. Comparison and fine mapping of both high and low neutralizing monoclonal antibodies against the principal neutralization domain of HIV-1 Arch. Virol. 126:129-146.
21. Leonard, C. K., M. W. Spellman, L. Riddle, R. J. Harris, J. N. Thomas, and T. J. Gregory. 1990. Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells. J. Biol. Chem. 265:10373-10382.
22. McKeating, J. A., J. Cordell, C. Dean, and P. Balfe. 1992. Synergistic interaction between ligands to the CD4 binding site and V3 domain of human immunodeficiency virus type 1 gp120. Virology 191:732-742.
23. McKeating, J. A., C. Shorten, J. Cordell, S. Graham, P. Balfe, N. Sullivan, M. Charles, M. Page, A. Bolmstedt, S. Olofsson, S. C. Kayman, Z. Wu, A. Pinter, C. Dean, J. Sodroski, and R. A. Weiss. 1993. Characterization of neutralizing monoclonal antibodies to linear and conformation-dependent epitopes within the first and second variable domains of human immunodeficiency virus type 1 gp120. J. Virol. 67:4932-4944.
24. Modrow, S., B. H. Hahn, G. M. Shaw, R. C. Gallo, F. Wong-Staal, and H. Wolf. 1987. Computer-assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates: prediction of antigeinc epitopes in conserved and variable domains. J. Virol. 61:570-578.
25. Moore, J. P. 1990 Simple methods for monitoring HIV-1 and HIV-2 gp120 binding to sCD4 by ELISA: HIV-2 has a 25-fold lower affinity than HIV-1 for sCD4 AIDS 3:297-305.
26. Moore, J. P., and D. D. Ho. 1992 Antibodies to discontinuous or conformationally sensitive epitopes on the gp120 glycoprotein of human immunodeficiency virus type 1 are highly prevalent in sera of infected humans, J. Virol. 67:863-875.
27. Moore, J. P., J. A. McKeating, I. M. Jones, P. E. Stephens, G. Clements, S. Thomson, and R. A. Weiss. 1990. Characterisation of recombinant gp120 and gp160 from HIV-1: binding to monoclonal antibodies and sCD4. AIDS 4:307-315.
28. Moore, J. P., Q. J. Sattentau, R. Wyatt, and J. Sodroski. 1994. Probing the structure of the surface glycoprotein gp120 of human immunodeficiency virus type 1 with a panel of monoclonal antibodies. J. Virol. 68:469-484.
29. Moore, J. P., Q. J. Sattentau, H. Yoshiyama, M. Thali, M. Charles, N. Sullivan, S.-W. Poon, M. S. Fung, F. Traincard, M. Pinkus, G. Robey, J. E. Robinson, D. D. Ho, and J. Sodroski. 1993. Probing the structure of the V2 domain of the human immunodeficiency virus type 1 surface glycoprotein gp120 with a panel of eight monoclonal antibodies: the human immune response to the V1 and V2 domains. J. Virol. 67:6136-6151.
30. Moore, J. P., and J. Sodroski. Unpublished results.
31. Moore, J. P., M. Thali, B. A. Jameson, F. Vignaux, G. K. Lewis, S.-W. Poon, M. S. Fung, P. J. Durda, L. Åkerblom, B. Wahren, D. D. Ho, Q. J. Sattentau, and J. Sodroski. 1993. Immunochemical analysis of the gp120 surface glycoprotein of human immunodeficiency virus type 1: probing the structure of the C4 and V4 domains and the interaction of the C4 domain with the V3 loop. J. Virol. 67:4785-4796.
32. Moore, J. P., R. L. Willey, G. K. Lewis, J. Robinson, and J. Sodroski. 1994. Immunological evidence for interactions between the first, second, and fifth conserved domains of the gp120 surface glycoprotein of human immunodeficiency virus type 1. J Virol. 68:6836-6847.
33. Moore, J. P., H. Yoshiyama, D. D. Ho, J. E. Robinson, and J. Sodroski. 1993. Antigenic variation in gp120s from molecular clones of HIV-1 LAI AIDS Res. Hum Retroviruses 9:1179-1187.
34. Niedrig, M., H.-P. Harthus, J. Hinkula, M. Broker, H. Bickhard, G. Pauli, H. R. Gelderblom, and B. Wahren. 1992. Inhibition of viral replication by monoclonal antibodies directed against human immunodeficiency virus gp120 J Gen. Virol. 73:2451-2455.
35. Olshevsky, U., E. Helseth, C. Furman, J. Li, W. Haseltine, and J. Sodroski. 1990. Identification of individual human immunodeficiency virus type 1 gp120 amino acids important for CD4 binding. J. Virol 64:5701-5707.
36. Potts, B. J., K. Field, V. Wu, M. Posner, L. Cavacini, and M. White-Scharf. 1993. Synergistic inhibition of HIV-1 by CD4 binding domain reagents and V3 directed monoclonal antibodies. Virology 197:415-419
37. Roben, P., J. P. Moore, M. Thali, J. Sodroski, C. F. Barbas III, and D. R. Burton. 1994. Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing ability to neutralize human immunodeficiency virus type 1. J. Virol 68:4821-4828.
38. Robinson, J. E., H. Yoshiyama, D. Holton, S. Elliott, and D. D. Ho. 1992 Distinct antigenic sites on HIV gp120 identified by a panel of human monoclonal antibodies, abstr Q449. J. Cell. Biochem Suppl 16E:71.
39. Sattentau, Q. J., and J. P. Moore. 1991. Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding. J. Exp. Med. 174:407-415
40. Sattentau, Q. J., J. P. Moore, F. Vignaux, F. Traincard, and P. Poignard. 1993. Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding. J. Virol 67:7383-7393.
41. Schutten, M., A. C. Andeweg, M. L. Bosch, and A. D. M. E. Osterhaus. 1995. Enhancement of infectivity of a non-syncytium inducing HIV-1 by sCD4 and by human antibodies that neutralize syncytium inducing HIV-1. Scand. J. Immunol. 41:18-22.
42. Shotton, C., C. Arnold, Q. Sattentau, J. Sodroski, and J. A. McKeating. 1995. Identification and characterization of monoclonal antibodies specific for polymorphic antigenic determinants within the V2 region of the human immunodeficiency virus type 1 envelope glycoprotein J Virol 69:222-230.
43. Skinner, M. A., R. Ting, A. J. Langlois, K. J. Weinhold, H. K. Lyerly, K. Javaherian, and T. J. Matthews. 1988. Characteristics of a neutralizing monoclonal antibody to the HIV envelope glycoprotein. AIDS Res Hum. Retroviruses 4:187-197.
44. Stamatatos, L., and C. Cheng-Mayer. 1993. Evidence that the structural conformation of envelope gp120 affects human immunodeficiency virus type 1 infectivity, host range, and syncytium-forming ability. J. Virol. 67:5635-5639.
45. Stareich, B. R., B. H. Hahn, G. M. Shaw, P. D. McNeely, S. Modrow, H. Wolf, W. P. Parks, S. F. Josephs, R. C. Gallo, and F. Wong-Staal. 1986. Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus, of AIDS. Cell 45:637-648.
46. Steimer, K. S., C. J. Scandella, P. V. Stiles, and N. L. Haigwood. 1991. Neutralization of divergent HIV-1 isolates by conformation-dependent human antibodies to gp120. Science 254:105-108.
47. 46a.Sullivan, N., and J. Sodroski. Unpublished observations.
48. Sullivan, N., Y. Sun, J. Li, W. Hoffmann, and J. Sodroski. 1995. Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates. J Virol 69:4413-4422.
49. Sullivan, N., M. Thali, C. Furman, D. Ho, and J. Sodroski. 1993. Effect of amino acid changes in the V2 region of the human immunodeficiency virus type 1 gp120 glycoprotein on subunit association, syncytium formation, and recognition by a neutralizing antibody. J. Virol. 67:3674-3679
50. Sun, N. C., D. D. Ho, C. R. Y. Sun, R-S. Liou, W. Gordon, M. S. C. Fung, X-L. Li, R. C. Ting, T-H. Lee, N. T. Chang, and T. W. Chang. 1989. Generation and characterization of monoclonal antibodies, to the putative CD4-binding domain of human immunodeficiency virus type 1 gp120 J. Virol. 63:3579-3585.
51. Thali, M., C. Furman, D. D. Ho, J. Robinson, S. Tilley, A. Pinter, and J. Sodroski. 1992 Discontinuous, conserved neutralization epitopss overlapping the CD4 binding region of the human immunodeficiency virus type 1 gp120 envelope glycoprotein. J Virol. 66:5635-5641.
52. Thali, M., C. Furman, B. Wahren, M. Posner, D. D. Ho, J. Robinson, and J. Sodroski. 1992 Cooperatively of neutralizing antibodies directed against the V3 and CD4 binding regions of the human immunodeficiency virus gp120 envelope glycoprotein J. Acquired Immune Defic Syndr. 5:591-599
53. Thali, M., J. P. Moore, C. Furman, M. Charles, D. D. Ho, J. Robinson, and J. Sodroski. 1993. Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding. J. Virol. 67:3978-3988.
54. Thali, M., U. Olshevsky, C. Furman, D. Gabuzda, M. Posner, and J. Sodroski. 1991. Characterization of a discontinuous human immunodeficiency virus type 1 gp120 epitope recognized by a broadly reactive neutralizing human monoclonal antibody. J. Virol 65:6188-6193.
55. Tilley, S. A., W. J. Honnen, M. E. Racho, T.-C. Chon, and A. Pinter. 1992. Synergistic neutralization of HIV-1 by human monoclonal antibodies against the V3 loop and the CD4-binding site of gp120. AIDS Res. Hum. Retroviruses 8:461-467.
56. Trkola, A., M. Purtscher, T. Muster, C. Ballaun, A. Buchacher, N. Sullivan, K. Srinivasan, J. Sodroski, J. P. Moore, and H. Katinger. 1996. Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1. J. Virol. 70: 1100-1108.
57. Veronese, F. D. M., R. Rahman, R. Pal, C. Boyer, J. Romano, V. S. Kalyanaraman, B. C. Nair, R. C. Gallo, and M. G. Sarngadharan. 1992. Delineation of immunoreactive, conserved regions in the external envelope glycoprotein of the human immunodeficiency virus type 1. AIDS Res. Hum. Retroviruses 8:1125-1132.
58. Willey, R. L., E. K. Ross, A. J. Buckler-White, T. S. Theodore, and M. A. Martin. 1989. Functional interaction of constant and variable domains of human immunodeficiency virus type 1 gp120. J. Virol. 63:3595-3600.
59. Willey, R. L., D. H. Smith, L. A. Lasky, T. S. Theodore, P. L. Earl, B. Mars, D. J. Capon, and M. A. Martin. 1988. In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity. J. Virol. 62:139-147.
60. Wyatt, R., J. P. Moore, M. Accola, E. Desjardin, J. Robinson, and J. Sodroski. 1995. The involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type t gp120 epitopes induced by receptor binding. J. Virol. 69:5723-5733.
61. Wyatt, R., N. Sullivan, M. Thali, H. Repke, D. Ho, J. Robinson, M. Posner, and J. Sodroski. 1993. Characterization of human immunodeficiency virus type 1 envelope glycoproteins containing deletions of the major variable regions. J. Virol. 67:4557-4565.
62. Wyatt, R., M. Thali, S. Tilley, A. Pinter, M, Posner, D. Ho, J. Robinson, and J. Sodroski. 1992. Relationship of the human immunodeficiency virus type 1 gp120 third variable loop to elements of the CD4 binding site. J Virol 66:6997-7004.